Advertisement

Statistical Challenges in Comparing Chemotherapy and Bone Marrow Transplantation as a Treatment for Leukemia

  • John P. Klein
  • Mei-Jie Zhang
Chapter

Abstract

Comparison of survival for patients treated with either post remission chemotherapy or allogeneic bone marrow transplantation (BMT) for leukemias is considered. Two designs for the comparison are considered. The first is a genetic randomized clinical trial. For this type of trial, comparisons can be made either by an intent-to-treat analysis or by a time dependent covariate model. The second design compares data from a multicenter chemotherapy trial with data from a large transplant registry. Here analysis is complicated by the registry only observing patients who are transplanted so adjustments needs to be made for patients who die or relapse while waiting for transplant. Corrections suggested for this source of bias are a matching technique, inclusion of a time dependent covariate and a left truncated Cox model. We examine these techniques through a small Monte Carlo study and compare how much information is lost by using registry data as compared to a genetically randomized trial.

Keywords

Acute Myelogenous Leukemia Allogeneic Bone Marrow Transplantation Monte Carlo Study Time Dependent Covariate Matched Pair Analysis 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Andersen, P. K., Borgan 0, Gill, R. D. and Keiding, N. (1993), Statistical Methods For Counting Processes, Springer-Verlag, New York.CrossRefGoogle Scholar
  2. Begg, C. B., McGlave, P. B., Bennett, J. M., Cassileth, P. A. and Oken, M. M. (1984), “A Critical Comparison Of Allogeneic Bone Marrow Transplantation And Conventional Chemotherapy As Treatment For Acute Nonlymphocytic Leukemia,” J. Clin. Oncol, 2, 369–78.Google Scholar
  3. Bortin, M. M., Horowitz, M. M. and Rimm, A. A. (1992), “Progress Report From The International Bone Marrow Transplant Registry,” Bone Marrow Trans, 10, 113–122.Google Scholar
  4. Cox, D. R. (1972), “Regression models and life tables (with discussion),” J. Roy. Statist. Soc. B, 34, 187–220.zbMATHGoogle Scholar
  5. Davis, K. (1988), “The Comprehensive Cohort Study: The Use Of Registry Data To Confirm And Extend A Randomized Trial,” Recent Results in Cancer Research, 111, 138–148.CrossRefGoogle Scholar
  6. Gale, R. P., Rees. J. K. H., Gray, R. G., Horowitz, M. M. (1991), “Chemotherapy Versus Transplants For Acute Myelogenous Leukemia In Second Remission,” Blood, 78 (Suppl 1): 49a.Google Scholar
  7. Horowitz, M. M. et al. (1991), “Comparison Of Chemotherapy And Bone Marrow Transplantation For Adults With Acute Lymphoblastic Leukemia In First Remission,” Ann Intern Med, 115, 13–18Google Scholar
  8. Mantel, N. and Byar, D. (1974), “Evaluation Of Response-Time Data Involving Transient Status: An Illustration Using Heart-Transplant Data, ” JASA, 69, 81–86.zbMATHGoogle Scholar
  9. Nowak, R. (1994), “ Problems In Clinical Trials Go Far Beyond Misconduct,” Science, 264, 1538–1541.CrossRefGoogle Scholar
  10. Turnbull, B. W., Brown, B. W. and Hu, M. (1974), “Survivorship Analysis Of Heart Transplant Data, ” JASA, 69, 74–80.Google Scholar

Copyright information

© Springer Science+Business Media Dordrecht 1996

Authors and Affiliations

  • John P. Klein
    • 1
    • 2
  • Mei-Jie Zhang
    • 1
    • 2
  1. 1.International Bone Marrow Transplant Registry Division of BiostatisticsThe Medical College of WisconsinMilwaukeeUSA
  2. 2.Division of BiostatisticsMedical College of WisconsinMilwaukeeUSA

Personalised recommendations